Skip to main content
Amwill Health Care Limited logo

Amwill Health Care Limited — Investor Relations & Filings

Ticker · 544353 ISIN · INE0U2L01017 BSE.NS Manufacturing
Filings indexed 2 across all filing types
Latest filing 2026-05-28 Regulatory Filings
Country IN India
Listing BSE.NS 544353

About Amwill Health Care Limited

https://www.amwillhealthcare.com

Amwill Health Care Limited specializes in the development, manufacturing, and distribution of a wide range of medical formulations. The company’s portfolio includes diverse therapeutic categories such as dermatology, gynecology, orthopedics, cardiology, and gastroenterology. Its product offerings comprise tablets, capsules, liquid orals, ointments, and injectables. The organization maintains a focus on quality control and adheres to standardized manufacturing practices to ensure product efficacy and safety. Beyond product development, the company provides third-party manufacturing services and operates through a distribution network that includes franchise models. By utilizing research-driven processes, the firm focuses on providing accessible medical solutions and enhancing patient care through a comprehensive supply chain.

Recent filings

Filing Released Lang Actions
Declaration of Non Applicability of Annual Secretarial Compliance is attched herewith.
Regulatory Filings Classification · 85% confidence The document is a short regulatory submission to the stock exchange under SEBI LODR, declaring that the Annual Secretarial Compliance Report is not applicable. It does not contain any financial statements or report itself, but is a compliance declaration, fitting the Regulatory Filings (RNS) category.
2026-05-28 English
Amwill Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve Audited Financial Results ....
Regulatory Filings Classification · 87% confidence The document is a formal intimation to the stock exchange under SEBI Listing Regulations about a forthcoming Board of Directors meeting date and agenda. It does not contain financial statements or constitute the Annual or Interim Report itself. It is a regulatory announcement of a board meeting rather than a management change, earnings release, or any detailed report. Therefore, it best fits the generic Regulatory Filings category (RNS).
2026-05-26 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.